Faculty profile

Hernan Gonorazky

Back to faculty

Associate ProfessorDepartment of PaediatricsUniversity of Toronto

Hernan Gonorazky

Associate Professor

Department of Paediatrics

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
55 publications in the last five years, latest in 2026.
Senior (last) author on 15 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2023.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

113

Publications

2,647

Citations

113

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Clinical Trial Networks Networks Neuromuscular Disease Open Science Patient Partnerships Preclinical Research Resources Training And Education Translational Research

Latest papers

Disease-modifying therapies for spinal muscular atrophy: Family experience, ethical considerations, and the role of social determinants of health.
Journal of neuromuscular diseases · 2026
Understanding the experiences of adults with spinal muscular atrophy & their transition to an adult program: A mixed methods study.
Journal of neuromuscular diseases · 2026
Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophy.
Journal of neurology · 2026

All 113 publications

Latest funding

NMD4C: the neuromuscular network for Canada
CIHR · 2023 · Principal investigator
$1,000,000
Real-World Evidence for Canadian Neuromuscular Disease: Establishing a Framework for National Integration of Patient Reported Outcomes, Clinical Registry Data, Healthcare Utilization and Healthcare Associated Costs
CIHR · 2023 · Co-investigator
$1,597,256
Exergaming registry-based trial promoting physical activity in children and adolescents with spinal muscular atrophy
CIHR · 2022 · Co-investigator
$1,777,095

All 4 grants and awards

113 publications.

Disease-modifying therapies for spinal muscular atrophy: Family experience, ethical considerations, and the role of social determinants of health.

Xiao L, Djordjevic D, Kang S, Gonorazky H, Chiang J, Ambreen M, Nigro E, Law E, Weinstock L, Amin R, McCradden MD

Journal of neuromuscular diseases20261 citationsOpen Access

DOI: 10.1177/22143602251375561 PMID: 40900034

Understanding the experiences of adults with spinal muscular atrophy & their transition to an adult program: A mixed methods study.

Munn J, Zaltz E, Izenberg A, Dale C, Ambreen M, Hammash N, Malik Z, Dhindsa A, Gonorazky H, Nigro E, Chiang J, Tandon A, Varadi R, McAdam L, Amin R, SickKids SMA Group

Journal of neuromuscular diseases20261 citationsOpen Access

DOI: 10.1177/22143602251377241 PMID: 40953063

Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophy.

Lochmüller H, Gonorazky H, Nigro E, Mah JK, Alemán A, Yaworski A, Oskoui M, Sbrocchi AM, Selby K, de Vera A, McAdam L, Gresko E, Linden A, Dutreix C, Hoffman EP

Journal of neurology20261 citationsOpen Access

DOI: 10.1007/s00415-026-13711-6 PMID: 41774261

Expanding Vamorolone Treatment Access for Canadians with Duchenne Muscular Dystrophy.

Mah JK, Lochmüller H, Ward L, Selby K, Gonorazky H, Sbrocchi AM, Wiles J, McMillan HJ, Campbell C, Mitton K, Worsfold N

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques2026Open Access

DOI: 10.1017/cjn.2026.10649 PMID: 42438401

Clinical Outcomes and Treatment Efficacy in Juvenile Myasthenia Gravis: A Retrospective Review From a Single Center

Tanitnun Paprad, Elisa Nigro, Zahra Aleisa, Freddy Paiz, Hernan Dario Gonorazky

Muscle & Nerve2026Senior authorOpen Access

DOI: 10.1002/mus.70408 PMID: 42749614

Factors Impacting Outcomes of Peripheral Nerve Blockade in Children With Charcot-Marie-Tooth Disease Undergoing Foot Surgery.

Bouchard M, Galán-Olleros M, Soni L, Harvey A, Jarvi S, Gonorazky H, Nigro E, de Ruiter J, Everett T, Munshey F

Paediatric anaesthesia2026

DOI: 10.1002/pan.70287 PMID: 42619438

Pediatric Cohort of Charcot-Marie-Tooth Disease: Clinical Features and Genetic Distribution.

Alawneh I, Alemán A, Nigro E, Bouchard M, Gonorazky HD

Neurology. Genetics2026Senior authorOpen Access

DOI: 10.1212/nxg.0000000000200339 PMID: 41450731

Equitable Access to Disease-Modifying Therapies for Canadian Children with SMA and Four SMN2 Copies

McMillan HJ, Gonorazky H, Campbell C, Chrestian N, Crone M, Dowling JJ, Joyal K, Kolski H, Leung E, Mackenzie A

Canadian Journal of Neurological Sciences20256 citationsOpen Access

DOI: 10.1017/cjn.2024.319

Clinical validity of congenital myopathy genes determined by the ClinGen Congenital Myopathies Expert Panel.

Ross JE, Flowers M, McNulty S, Patel M, Yang H, Palus B, Abdelmoneim Elnagheeb M, Eng L, Owens E, Beggs AH, Bertini E, D'Amico A, Donkervoort S, Dowling J, Fattori F, Ferreiro A, Genetti CA, Gonorazky H, Lek M, Lindy A, Medne L, Muntoni F, Pajusalu S, Pelin K, Rendu J, Sarkozy A, Vatta M, Winder T, Yoon G, Bönnemann CG, Ceyhan-Birsoy O

Journal of neuromuscular diseases20253 citationsOpen Access

DOI: 10.1177/22143602251339369 PMID: 40491337

Bi-allelic PRMT9 loss-of-function variants cause a syndromic form of intellectual disability

Ariane Kröll‐Hermi, Corinne Stoetzel, Christelle Etard, Levon Halabelian, Élise Schaefer, Sophie Scheidecker, Kimia Kahrizi, Jamali Payman, Véronique Geoffroy, Megana K. Prasad, Cathy Obringer, Laurie Ruch, Amandine Girard, Hong Zeng, Fengling Li, Damien Plassard, Céline Keime, Francesca Mattioli, Claire Feger, Amélie Piton, Atsushi Fujita, Naomichi Matsumoto, Matheus Augusto Araújo Castro, Chong Ae Kim, Lyse Ruaud, Jonathan Lévy, Blandine Dozières, Anne‐Claude Tabet, Ingrid M. Wentzensen, Teresa Santiago‐Sim, et al. (89 authors)

The American Journal of Human Genetics20251 citationsOpen Access

DOI: 10.1016/j.ajhg.2025.10.014 PMID: 41260215

NMD4C: the neuromuscular network for Canada

Principal investigatorCIHR2023Network Gr. in Skin Health, Bone Health, and Muscular Dyst. - Muscular Dystrophy

Principal investigators: Lochmüller, Hanns; Osman, Homira; Brais, Bernard; Campbell, Craig Gordon N; Chang, Natasha C; Dowling, James; Gagnon, Cynthia; Gonorazky, Hernan D; Hodgkinson, Victoria; Karamchandani, Jason; Korngut, Lawrence W; Kothary, Rashmi K; Mah, Jean K; O'Connell, Colleen; Patten, Kessen; Rossi, Fabio M; Schellenberg, Kerri; Selby, Kathryn A; Warman Chardon, Jodi

Keywords: Clinical Trial Networks; Networks; Neuromuscular Disease; Open Science; Patient Partnerships; Preclinical Research Resources; Training And Education; Translational Research

$1,000,000

Real-World Evidence for Canadian Neuromuscular Disease: Establishing a Framework for National Integration of Patient Reported Outcomes, Clinical Registry Data, Healthcare Utilization and Healthcare Associated Costs

Co-investigatorCIHR2023Team Grant: Improving Health and Admin Data and Monitor Rare Diseases

Principal investigators: Amin, Reshma; Osman, Homira; Cohen, Eyal; Hodgkinson, Victoria; Jewett, Gordon; Lochmüller, Hanns

Keywords: Health Services Research; Healthcare Service Utilization; Neuromuscular Disease; Registry

$1,597,256

Exergaming registry-based trial promoting physical activity in children and adolescents with spinal muscular atrophy

Co-investigatorCIHR2022Operating Grant: Clinical Trials Projects

Principal investigators: Oskoui, Maryam; Smith, Maureen M; Evans, Alan C; Iturria Medina, Yasser; Levac, Danielle E; Potter, Elizabeth K

Keywords: Exergaming; Pragmatic Randomized Controlled Trial; Rare Disease; Registry-Based Trial; Rehabilitation; Spinal Muscular Atrophy; Wearable Technology

$1,777,095

Exergaming registry-based trial promoting physical activity in children and adolescents with spinal muscular atrophy

Co-investigatorCIHR2022Operating Grant: Clinical Trials Projects - Indirect Costs

Principal investigators: Oskoui, Maryam; Smith, Maureen M; Evans, Alan C; Iturria Medina, Yasser; Levac, Danielle E; Potter, Elizabeth K

Keywords: Exergaming; Pragmatic Randomized Controlled Trial; Rare Disease; Registry-Based Trial; Rehabilitation; Spinal Muscular Atrophy; Wearable Technology

$444,274

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Hernan Gonorazky

Research

Latest papers

Latest funding

Disease-modifying therapies for spinal muscular atrophy: Family experience, ethical considerations, and the role of social determinants of health.

Understanding the experiences of adults with spinal muscular atrophy & their transition to an adult program: A mixed methods study.

Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to&#x2009;<&#x2009;18-year-old boys with duchenne muscular dystrophy.

Expanding Vamorolone Treatment Access for Canadians with Duchenne Muscular Dystrophy.

Clinical Outcomes and Treatment Efficacy in Juvenile Myasthenia Gravis: A Retrospective Review From a Single Center

Factors Impacting Outcomes of Peripheral Nerve Blockade in Children With Charcot-Marie-Tooth Disease Undergoing Foot Surgery.

Pediatric Cohort of Charcot-Marie-Tooth Disease: Clinical Features and Genetic Distribution.

Equitable Access to Disease-Modifying Therapies for Canadian Children with SMA and Four SMN2 Copies

Clinical validity of congenital myopathy genes determined by the ClinGen Congenital Myopathies Expert Panel.

Bi-allelic PRMT9 loss-of-function variants cause a syndromic form of intellectual disability

NMD4C: the neuromuscular network for Canada

Real-World Evidence for Canadian Neuromuscular Disease: Establishing a Framework for National Integration of Patient Reported Outcomes, Clinical Registry Data, Healthcare Utilization and Healthcare Associated Costs

Exergaming registry-based trial promoting physical activity in children and adolescents with spinal muscular atrophy

Exergaming registry-based trial promoting physical activity in children and adolescents with spinal muscular atrophy

Frequent collaborators

James Dowling

Maryam Oskoui

Craig Campbell

Mark Tarnopolsky

Jean Mah

Kathryn Selby

Reshma Amin

Ronald Cohn

Lili-Naz Hazrati

Lena Xiao

Michael Brudno

Hanns Lochmüller

Grace Yoon

Bernard Brais

Jackie Chiang

Laura McAdam

Jodi Warman Chardon

Christian Marshall

Jordan Sheriko

Lawrence Korngut

Roberto Mendoza-Londono

Jiri Vajsar

Carolina Gorodetsky

Sohee Kang

Michal Inbar-Feigenberg

Simona Hasal

Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophy.